RxSight Inc

RxSight Inc

RXST

Get informed when a big investor buys or sells

+ Follow
Market Cap$248.79M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
RxSight IncRxSight Inc-5.3--17%2.1-
$7.67

Target Price by Analysts

22.7% upsideRxSight Target Price DetailsTarget Price

Share Statistics

Market cap$248.79 Million
Enterprise Value$242.05 Million
Dividend Yield$- (-)
Earnings per Share$-0.95
Beta1.15
Outstanding Shares41,306,110

Return

Return on Equity-17.45%ROE
Return on Assets-15.34%
Return on Invested Capital-19.21%

Valuation & Multiples

P/E Ratio-5.32P/E Ratio
PEG-5.66PEG
Price to Sales2.08Price to Sales
Price to Book Ratio1.04Price to Book Ratio
Enterprise Value to Revenue1.9
Enterprise Value to EBIT-4.55
Enterprise Value to Net Income-6
Total Debt to Enterprise0.04
Debt to Equity0.04Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 12, 2026
EPS Estimate
$-0.31
Average shareholder expectation
Revenue Estimate
$29.97 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 5, 2026
EPS Estimate
$-0.21
Average shareholder expectation
Revenue Estimate
$32.55 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio4.8525 415.05%
Total Calls12,200 41.35%
Total Puts59,200 305.48%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %92.76% 3.77%
Total Invested$235.20M 38.40%
Investors Holding1650%

ESG Score

No data

About RxSight Inc

2,021 employees